University of North Carolina at Chapel Hill
Date of Award
Crohn's Disease, Other
Term of Grant
COVID-19 Vaccine Effectiveness in Patients with IBD Treated with Immune Suppression Partnership to Report Effectiveness of Vaccination in populations Excluded from iNitial Trials of COVID (PREVENT-COVID)
This project will generate important real-world evidence to fill important research gaps, including overall COVID-19 vaccine effectiveness, immunogenicity, and safety among IBD patients. The study will also identify medication-related and/or disease-related factors that may be associated with diminished immune response. These data can be used to guide patient decisions about immunization and will provide guidance on the degree of COVID-19 risk following immunization.